Cargando…

Platelets as Mediators of Thromboinflammation in Chronic Myeloproliferative Neoplasms

Chronic myeloproliferative neoplasms (MPN) are stem cell disorders driven by mutations in JAK2, CALR, or MPL genes and characterized by myeloid proliferation and increased blood cell counts. They encompass three closely related conditions, including essential thrombocythemia, polycythemia vera, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marin Oyarzún, Cecilia P., Heller, Paula G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587101/ https://www.ncbi.nlm.nih.gov/pubmed/31258539 http://dx.doi.org/10.3389/fimmu.2019.01373

Ejemplares similares

Thromboinflammation in Myeloproliferative Neoplasms (MPN)—A Puzzle Still to Be Solved
por: Bhuria, Vikas, et al.
Publicado: (2022)

Platelets, Thromboinflammation and Neurovascular Disease
por: Sun, Ying, et al.
Publicado: (2022)

The role of platelet mediated thromboinflammation in acute liver injury
por: Morris, Sean M., et al.
Publicado: (2022)

Platelets and Immune Responses During Thromboinflammation
por: Mezger, Matthias, et al.
Publicado: (2019)

Editorial: Platelets and Immune Responses During Thromboinflammation
por: Schattner, Mirta, et al.
Publicado: (2020)

Neutrophil extracellular trap formation and circulating nucleosomes in patients with chronic myeloproliferative neoplasms
por: Marin Oyarzún, Cecilia P., et al.
Publicado: (2016)

Inflammation Induced by Platelet-Activating Viperid Snake Venoms: Perspectives on Thromboinflammation
por: Teixeira, Catarina, et al.
Publicado: (2019)

The Era of Thromboinflammation: Platelets Are Dynamic Sensors and Effector Cells During Infectious Diseases
por: Guo, Li, et al.
Publicado: (2019)

Platelet-monocyte aggregates: molecular mediators of thromboinflammation
por: Rolling, Christina C., et al.
Publicado: (2023)

Chemokines, molecular drivers of thromboinflammation and immunothrombosis
por: Leberzammer, Julian, et al.
Publicado: (2023)

Platelets, Macrophages, and Thromboinflammation in Chagas Disease
por: Choudhuri, Subhadip, et al.
Publicado: (2022)

Hypothetical Atopic Dermatitis-Myeloproliferative Neoplasm Syndrome
por: Kawakami, Toshiaki, et al.
Publicado: (2015)

Metabolic Vulnerabilities and Epigenetic Dysregulation in Myeloproliferative Neoplasms
por: Sharma, Vasundhara, et al.
Publicado: (2020)

Inflammatory Pathophysiology as a Contributor to Myeloproliferative Neoplasms
por: Fisher, Daniel Arthur Corpuz, et al.
Publicado: (2021)

The Role of CLEC-2 and Its Ligands in Thromboinflammation
por: Meng, Danyang, et al.
Publicado: (2021)

Role of antimicrobial peptide cathelicidin in thrombosis and thromboinflammation
por: Zhang, Qing, et al.
Publicado: (2023)

Platelet Toll-Like Receptors Mediate Thromboinflammatory Responses in Patients With Essential Thrombocythemia
por: Marín Oyarzún, Cecilia P., et al.
Publicado: (2020)

Iatrogenic air embolism: pathoanatomy, thromboinflammation, endotheliopathy, and therapies
por: Marsh, Phillip L., et al.
Publicado: (2023)

Patients With Myeloproliferative Neoplasms Harbor High Frequencies of CD8 T Cell-Platelet Aggregates Associated With T Cell Suppression
por: Carnaz Simões, Ana Micaela, et al.
Publicado: (2022)

Corrigendum: Patients with myeloproliferative neoplasms harbor high frequencies of CD8 T cell-platelet aggregates associated with T cell suppression
por: Simões, Ana Micaela Carnaz, et al.
Publicado: (2022)

Platelet‐inspired nanomedicine in hemostasis thrombosis and thromboinflammation
por: Raghunathan, Shruti, et al.
Publicado: (2022)

Message in a platelet: decoding platelet transcriptomes in myeloproliferative neoplasms
por: Shapiro, Susan, et al.
Publicado: (2021)

Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19
por: Peerschke, Ellinor I., et al.
Publicado: (2021)

Beyond Hemostasis: Platelet Innate Immune Interactions and Thromboinflammation
por: Mandel, Jonathan, et al.
Publicado: (2022)

Emerging Role of Neutrophils in the Thrombosis of Chronic Myeloproliferative Neoplasms
por: Ferrer-Marín, Francisca, et al.
Publicado: (2021)

Philadelphia-negative chronic myeloproliferative neoplasms
por: Bittencourt, Rosane Isabel, et al.
Publicado: (2012)

Myeloproliferative neoplasms
por: Cross, Nick
Publicado: (2019)

Myeloproliferative neoplasms
por: Kiladjian, Jean-Jacques
Publicado: (2018)

Platelet transcriptome identifies progressive markers and potential therapeutic targets in chronic myeloproliferative neoplasms
por: Shen, Zhu, et al.
Publicado: (2021)

Platelet proteo-transcriptomic profiling validates mediators of thrombosis and proteostasis in patients with myeloproliferative neoplasms
por: Kelliher, Sarah, et al.
Publicado: (2023)

Myeloproliferative Neoplasms and Aspirin: Does Increased Platelet Turnover Matter?
por: Koçak Göktürk, Ilgın, et al.
Publicado: (2023)

Role of CD39 in COVID-19 Severity: Dysregulation of Purinergic Signaling and Thromboinflammation
por: Díaz-García, Elena, et al.
Publicado: (2022)

Platelets Promote Thromboinflammation in SARS-CoV-2 Pneumonia
por: Taus, Francesco, et al.
Publicado: (2020)

Platelet Versus Megakaryocyte: Who Is the Real Bandleader of Thromboinflammation in Sepsis?
por: Garcia, Cédric, et al.
Publicado: (2022)

Chronic Myeloproliferative Neoplasms: a Collaborative Approach
por: Pieri, Lisa, et al.
Publicado: (2010)

Coexistence of Chronic Lymphocytic Leukemia and Myeloproliferative Neoplasm
por: Zielinska, Patrycja, et al.
Publicado: (2014)

Chronic Myeloproliferative Neoplasms: Some Remaining Challenges
por: Mughal, Tariq I., et al.
Publicado: (2018)

Mediators of Inflammation in Myeloproliferative Neoplasms: State of the Art
por: Hermouet, Sylvie, et al.
Publicado: (2015)

Epigenetics in Myeloproliferative Neoplasms
por: McPherson, Suzanne, et al.
Publicado: (2017)

Aetiology of Myeloproliferative Neoplasms
por: McMullin, Mary Frances, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uqbje3vgs8ruml1rvmnqgdhvkh